88-91-5 Usage
Uses
Used in Chemical Industry:
4-CHLORO-3,5-DINITROBENZENESULFONIC ACID is used as a strong sulfonating agent for the production of dyes, pharmaceuticals, and other organic compounds, due to its ability to facilitate the formation of sulfonic acid derivatives.
Used in Analytical Chemistry:
In the field of analytical chemistry, 4-CHLORO-3,5-DINITROBENZENESULFONIC ACID is used as a reagent for the determination of amino acids, proteins, and peptides, leveraging its capacity to interact with these biomolecules and aid in their identification and quantification.
Used in Disease and Disorder Research:
4-CHLORO-3,5-DINITROBENZENESULFONIC ACID is also being investigated for its potential use in the treatment of certain diseases and disorders, capitalizing on its chemical properties to explore its therapeutic effects and possible applications in medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 88-91-5 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 8 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 88-91:
(4*8)+(3*8)+(2*9)+(1*1)=75
75 % 10 = 5
So 88-91-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClN2O7S/c7-6-4(8(10)11)1-3(17(14,15)16)2-5(6)9(12)13/h1-2H,(H,14,15,16)
88-91-5Relevant articles and documents
Construction of phenoxazine rings containing nitro and sulfonic acid groups leading to phenoxazine-3-sulfonamide derivatives: Their evaluation as novel and potential insulin secretagogues
Reddy, Seelam Venkata,Rao, Gangula Mohan,Kumar, Baru Vijaya,Reddy, Koppela Naresh,Sravya, Konda,Goverdhan, Puchchakayala,Rathore, Vandana,Deora, Girdhar Singh,Pal, Manojit
, p. 587 - 592 (2014)
A series of N-(alkyl/aryl/heteroaryl)-1-nitro-10H-phenoxazine-3- sulfonamides was designed, synthesized and evaluated for its hypoglycemic, hyperglycemic and oral anti-diabetic activities. These compounds were prepared via the construction of a phenoxazine ring containing nitro and sulfonic acid groups in a single step followed by further transformations. One of these compounds exhibited promising anti-diabetic activities comparable to glibenclamide and increased serum insulin levels indicating its potential as a novel insulin secretagogue. This journal is the Partner Organisations 2014.